Regional/Distant Stage Female Breast Cancer Incidence by Year, White Individuals, New York State Excl New York City, 1976-2020
Source: New York State Cancer Registry
Year of Diagnosis | Cases | Rate per 100,000 Females | 95% CI |
---|---|---|---|
1976 | 2225 | 44.7 | 42.9-46.7 |
1977 | 2283 | 45.8 | 43.9-47.8 |
1978 | 2505 | 49.7 | 47.7-51.7 |
1979 | 2350 | 46.2 | 44.3-48.2 |
1980 | 2499 | 48.8 | 46.8-50.8 |
1981 | 2493 | 48.7 | 46.8-50.7 |
1982 | 2541 | 49.2 | 47.2-51.2 |
1983 | 2691 | 52.1 | 50.1-54.2 |
1984 | 2587 | 49.3 | 47.4-51.3 |
1985 | 2734 | 52.3 | 50.3-54.3 |
1986 | 2680 | 51.1 | 49.1-53.1 |
1987 | 2657 | 50.3 | 48.3-52.3 |
1988 | 2526 | 47.3 | 45.4-49.2 |
1989 | 2199 | 41.1 | 39.4-42.9 |
1990 | 2297 | 42.7 | 41.0-44.6 |
1991 | 2188 | 40.3 | 38.6-42.0 |
1992 | 2175 | 40.1 | 38.4-41.9 |
1993 | 2112 | 38.7 | 37.1-40.4 |
1994 | 2228 | 40.7 | 39.0-42.4 |
1995 | 2297 | 41.5 | 39.8-43.3 |
1996 | 2401 | 43.4 | 41.6-45.2 |
1997 | 2475 | 44.4 | 42.6-46.2 |
1998 | 2384 | 42.4 | 40.7-44.2 |
1999 | 2395 | 42.3 | 40.6-44.0 |
2000 | 2462 | 43.1 | 41.4-44.8 |
2001 | 2431 | 42.3 | 40.6-44.0 |
2002 | 2481 | 42.7 | 41.0-44.5 |
2003 | 2658 | 45.5 | 43.8-47.3 |
2004 | 2711 | 45.9 | 44.2-47.7 |
2005 | 2736 | 46.0 | 44.2-47.7 |
2006 | 2779 | 46.6 | 44.8-48.4 |
2007 | 2773 | 46.2 | 44.5-48.0 |
2008 | 2753 | 45.9 | 44.2-47.7 |
2009 | 2820 | 46.3 | 44.6-48.1 |
2010 | 2631 | 43.3 | 41.6-45.0 |
2011 | 2672 | 43.6 | 41.9-45.4 |
2012 | 2566 | 41.6 | 40.0-43.4 |
2013 | 2652 | 43.1 | 41.4-44.9 |
2014 | 2729 | 44.0 | 42.3-45.8 |
2015 | 2650 | 43.3 | 41.5-45.1 |
2016 | 2516 | 41.0 | 39.3-42.7 |
2017 | 2490 | 40.9 | 39.2-42.7 |
2018 | 2524 | 40.9 | 39.2-42.6 |
2019 | 2504 | 40.5 | 38.8-42.3 |
2020 | 2280 | 36.9 | 35.3-38.6 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 20 cases per year are unstable and should be used with caution.
- Regional/distant stage indicates disease has spreaded beyond the limits of the organ of origin at diagnosis.